Scientific paper - Case study
Incidental detection of breast cancer by 18F-fluorocholine PET/CT performed for primary hyperparathyroidism
Nuclear Medicine Review, 25 (2022), 1; 66-67. https://doi.org/10.5603/NMR.a2022.0013

Jozanović, Vlatka; Huić, Dražen

Cite this document

Jozanović, V. & Huić, D. (2022). Incidental detection of breast cancer by 18F-fluorocholine PET/CT performed for primary hyperparathyroidism. Nuclear Medicine Review, 25. (1), 66-67. doi: 10.5603/NMR.a2022.0013

Jozanović, Vlatka and Dražen Huić. "Incidental detection of breast cancer by 18F-fluorocholine PET/CT performed for primary hyperparathyroidism." Nuclear Medicine Review, vol. 25, no. 1, 2022, pp. 66-67. https://doi.org/10.5603/NMR.a2022.0013

Jozanović, Vlatka and Dražen Huić. "Incidental detection of breast cancer by 18F-fluorocholine PET/CT performed for primary hyperparathyroidism." Nuclear Medicine Review 25, no. 1 (2022): 66-67. https://doi.org/10.5603/NMR.a2022.0013

Jozanović, V. and Huić, D. (2022) 'Incidental detection of breast cancer by 18F-fluorocholine PET/CT performed for primary hyperparathyroidism', Nuclear Medicine Review, 25(1), pp. 66-67. doi: 10.5603/NMR.a2022.0013

Jozanović V, Huić D. Incidental detection of breast cancer by 18F-fluorocholine PET/CT performed for primary hyperparathyroidism. Nuclear Medicine Review [Internet]. 2022 [cited 2024 December 19];25(1):66-67. doi: 10.5603/NMR.a2022.0013

V. Jozanović and D. Huić, "Incidental detection of breast cancer by 18F-fluorocholine PET/CT performed for primary hyperparathyroidism", Nuclear Medicine Review, vol. 25, no. 1, pp. 66-67, 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:616507. [Accessed: 19 December 2024]

Please login to the repository to save this object to your list.